The Fort Worth Press - US researchers seek to legitimize AI mental health care

USD -
AED 3.672498
AFN 64.500824
ALL 80.947117
AMD 360.429701
ANG 1.789785
AOA 918.000215
ARS 1545.652697
AUD 1.453288
AWG 1.8025
AZN 1.701999
BAM 1.743549
BBD 2.014201
BDT 124.684633
BGN 1.747831
BHD 0.377278
BIF 2991.682342
BMD 1
BND 1.278494
BOB 11.860357
BRL 5.587502
BSD 1.00008
BTN 93.98513
BWP 13.720001
BYN 2.994357
BYR 19600
BZD 2.011304
CAD 1.416515
CDF 2290.999934
CHF 0.824095
CLF 0.024781
CLP 975.250136
CNY 6.672801
CNH 6.67617
COP 3289.15
CRC 452.34508
CUC 1
CUP 24.001212
CVE 98.299494
CZK 21.77485
DJF 178.081276
DKK 6.686203
DOP 60.656578
DZD 136.445001
EGP 53.330401
ERN 15
ETB 162.77021
EUR 0.894419
FJD 2.25945
FKP 0.745155
GBP 0.747565
GEL 2.589966
GGP 0.745155
GHS 11.710587
GIP 0.745155
GMD 73.999764
GNF 8859.687441
GTQ 7.641802
GYD 209.550384
HKD 7.845125
HNL 26.881572
HRK 6.76901
HTG 131.085575
HUF 325.441992
IDR 18113
ILS 3.173025
IMP 0.745155
INR 93.60345
IQD 1516.057857
IRR 1902285.500127
ISK 122.497478
JEP 0.745155
JMD 158.721951
JOD 0.708989
JPY 158.63195
KES 129.890073
KGS 87.449804
KHR 4078.557929
KMF 439.000208
KPW 899.999961
KRW 1342.804987
KWD 0.310999
KYD 0.833363
KZT 446.483971
LAK 22510.073815
LBP 89553.682465
LKR 332.358631
LRD 169.999198
LSL 16.395017
LTL 2.95274
LVL 0.60489
LYD 6.410662
MAD 9.755417
MDL 17.970617
MGA 4537.674286
MKD 55.039186
MMK 2099.696522
MNT 3601.450067
MOP 8.080107
MRU 40.34233
MUR 46.919873
MVR 15.410049
MWK 1734.122597
MXN 18.697235
MYR 4.056301
MZN 63.910287
NAD 16.39487
NGN 1348.029871
NIO 36.800956
NOK 9.493449
NPR 150.377549
NZD 1.78293
OMR 0.38451
PAB 1.000071
PEN 3.408278
PGK 4.491377
PHP 63.042501
PKR 276.58297
PLN 3.930145
PYG 6173.609935
QAR 3.645457
RON 4.780302
RSD 105.219033
RUB 82.99589
RWF 1479.602753
SAR 3.760416
SBD 8.097299
SCR 13.818913
SDG 601.502956
SEK 9.847375
SGD 1.280925
SHP 0.744075
SLE 22.950157
SLL 20969.504398
SOS 571.530455
SRD 37.546011
STD 20697.981008
STN 21.841652
SVC 8.750925
SYP 13001.999685
SZL 16.399741
THB 33.562503
TJS 9.190242
TMT 3.51
TND 2.980472
TOP 2.40776
TRY 50.232805
TTD 6.782502
TWD 32.982045
TZS 2643.085006
UAH 45.486291
UGX 4080.286342
UYU 40.464463
UZS 11975.30589
VES 897.18025
VND 25600
VUV 120.001108
WST 2.780103
XAF 586.700731
XAG 0.019223
XAU 0.000246992862
XCD 2.70255
XCG 1.802321
XDR 0.707052
XOF 586.700731
XPF 106.319815
YER 236.509359
ZAR 16.493202
ZMK 9001.199239
ZMW 20.375579
ZWL 321.999592
SSP 5745.814556
MXV 2.101363
  • RIO

    -0.3300

    97.04

    -0.34%

  • CMSC

    -0.0400

    20.67

    -0.19%

  • RELX

    0.0000

    33.41

    0%

  • RBGPF

    0.0000

    67.95

    0%

  • BCE

    -0.0700

    21.99

    -0.32%

  • BCC

    -0.0300

    75.66

    -0.04%

  • GSK

    0.8600

    51.08

    +1.68%

  • JRI

    -0.0300

    11.52

    -0.26%

  • NGG

    -0.1200

    76.68

    -0.16%

  • CMSD

    0.0900

    20.54

    +0.44%

  • BTI

    -0.0800

    55.75

    -0.14%

  • AZN

    2.0200

    168.1

    +1.2%

  • BP

    -1.4200

    43.16

    -3.29%

  • RYCEF

    0.4600

    19.7

    +2.34%

  • VOD

    0.0700

    17.02

    +0.41%

US researchers seek to legitimize AI mental health care
US researchers seek to legitimize AI mental health care / Photo: © GETTY IMAGES NORTH AMERICA/AFP/File

US researchers seek to legitimize AI mental health care

Researchers at Dartmouth College believe artificial intelligence can deliver reliable psychotherapy, distinguishing their work from the unproven and sometimes dubious mental health apps flooding today's market.

Text size:

Their application, Therabot, addresses the critical shortage of mental health professionals.

According to Nick Jacobson, an assistant professor of data science and psychiatry at Dartmouth, even multiplying the current number of therapists tenfold would leave too few to meet demand.

"We need something different to meet this large need," Jacobson told AFP.

The Dartmouth team recently published a clinical study demonstrating Therabot's effectiveness in helping people with anxiety, depression and eating disorders.

A new trial is planned to compare Therabot's results with conventional therapies.

The medical establishment appears receptive to such innovation.

Vaile Wright, senior director of health care innovation at the American Psychological Association (APA), described "a future where you will have an AI-generated chatbot rooted in science that is co-created by experts and developed for the purpose of addressing mental health."

Wright noted these applications "have a lot of promise, particularly if they are done responsibly and ethically," though she expressed concerns about potential harm to younger users.

Jacobson's team has so far dedicated close to six years to developing Therabot, with safety and effectiveness as primary goals.

Michael Heinz, psychiatrist and project co-leader, believes rushing for profit would compromise safety.

The Dartmouth team is prioritizing understanding how their digital therapist works and establishing trust.

They are also contemplating the creation of a nonprofit entity linked to Therabot to make digital therapy accessible to those who cannot afford conventional in-person help.

- Care or cash? -

With the cautious approach of its developers, Therabot could potentially be a standout in a marketplace of untested apps that claim to address loneliness, sadness and other issues.

According to Wright, many apps appear designed more to capture attention and generate revenue than improve mental health.

Such models keep people engaged by telling them what they want to hear, but young users often lack the savvy to realize they are being manipulated.

Darlene King, chair of the American Psychiatric Association's committee on mental health technology, acknowledged AI's potential for addressing mental health challenges but emphasizes the need for more information before determining true benefits and risks.

"There are still a lot of questions," King noted.

To minimize unexpected outcomes, the Therabot team went beyond mining therapy transcripts and training videos to fuel its AI app by manually creating simulated patient-caregiver conversations.

While the US Food and Drug Administration theoretically is responsible for regulating online mental health treatment, it does not certify medical devices or AI apps.

Instead, "the FDA may authorize their marketing after reviewing the appropriate pre-market submission," according to an agency spokesperson.

The FDA acknowledged that "digital mental health therapies have the potential to improve patient access to behavioral therapies."

- Therapist always in -

Herbert Bay, CEO of Earkick, defends his startup's AI therapist Panda as "super safe."

Bay says Earkick is conducting a clinical study of its digital therapist, which detects emotional crisis signs or suicidal ideation and sends help alerts.

"What happened with Character.AI couldn't happen with us," said Bay, referring to a Florida case in which a mother claims a chatbot relationship contributed to her 14-year-old son's death by suicide.

AI, for now, is suited more for day-to-day mental health support than life-shaking breakdowns, according to Bay.

"Calling your therapist at two in the morning is just not possible," but a therapy chatbot remains always available, Bay noted.

One user named Darren, who declined to provide his last name, found ChatGPT helpful in managing his traumatic stress disorder, despite the OpenAI assistant not being designed specifically for mental health.

"I feel like it's working for me," he said.

"I would recommend it to people who suffer from anxiety and are in distress."

F.Carrillo--TFWP